(±)-Pantoprazole sodium, [(±)-PAN•Na], is a proton pump inhibitor that is administered as a racemate. The protective effects of (-)-PAN•Na, (+)-PAN•Na and (±)-PAN•Na on various experimental ulcers in animals were compared. (-)-PAN•Na inhibited gastric lesions induced by water-immersion stress, aspirin, ethanol, and reserpine in a dose-dependent manner. The dose that inhibited 50% of lesions (ID 50 ) were 2.72 ± 1.03, 1.60 ± 0.64, 4.12 ± 2.18, and 2.77 ± 0.86 mg/kg, respectively. The ID 50 values of (+)-PAN•Na and (±)-PAN•Na were 1.7, 2.6, 1.8, 2.7 and 1.5, 1.7, 1.6, 1.9 times higher, respectively, than that of (-)-PAN•Na. Primary culture of rat gastric epithelial cells was investigated as an in vitro model for comparing the cell protective effects among the three agents. Exposed to the three drugs at the concentrations of 2.5 × 10 -1 -2.5 × 10 -5 mg/ml, cultured cells were treated with either pH 3.5 medium or 3.5 mM indomethacin. Cytoprotection was evaluated by MTT. (-)-PAN•Na, (+)-PAN•Na and (±)-PAN•Na provided significant cytoprotective effects when the cells were pretreated with the drugs prior to exposure to 3.5 mM indomethacin, whereas, when they were treated concurrently, no significant cytoprotective effects were found. In pH 3.5 medium-induced damage, the three drugs had marked protective effects on gastric cells, however, when the concentration of drugs was high (0.25 mg/ml), only (+)-PAN•Na had significant cytoprotection. We concluded that the cytoprotective mechanisms of (-)-PAN•Na and (+)-PAN•Na are different. The results of in vitro experiments were not in complete accordance with the in vivo results, suggesting that the effects of the three drugs on ulcer inhibition are mainly due to the effects of acid inhibition rather than cytoprotection.